RxDoctor Payments Data

Kimberly Gray, PA

Physician Assistant · Lexington, KYNPI 1770749087

Payments from drug & device makers

$916in general payments, 2019–2025

Across 47 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$147
  • Novo Nordisk$101
  • Lilly USA, LLC$92
  • Exact Sciences$88
  • GSK$58
  • Amgen$57
  • plus $373 from 12 others

What the payments were for

  • Food & beverage$89998%
  • Education$172%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$916 in reported general payments places this provider in the 65th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$43,500
Medicare patients
155
Services billed
1,428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide61$68,941
OzempicSemaglutide68$68,274
EliquisApixaban63$60,128
JardianceEmpagliflozin41$38,048
TrulicityDulaglutide19$26,087
JanuviaSitagliptin Phosphate22$21,244
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$11,712
SymbicortBudesonide/Formoterol Fumarate22$9,122
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$2,972
Levothyroxine Sodium290$2,862
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$1,941
Novolin NInsulin Nph Human Isophane11$1,923
Albuterol Sulfate HfaAlbuterol Sulfate76$1,915
Pravastatin Sodium149$1,736
Dicyclomine Hcl64$1,584

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$92$95,02880 claims
Novo NordiskOzempic$101$68,27468 claims
PfizerEliquis$40$60,12863 claims
Boehringer IngelheimJardiance$32$38,04841 claims
AstraZenecaSymbicort$41$9,12222 claims
AbbVieSynthroid$147$1,45424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →